Abcellera Biologics
Quarterly Financials
| Values in thousands | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|
| Revenue | $9,954 | $9,179 | $6,599 | $10,056 |
| Gross Profit | 3,188 | 70 | -810 | 2,800 |
| EBITDA | -48,128 | -53,568 | -44,653 | -39,557 |
| EBIT | -54,894 | -62,677 | -52,062 | -46,813 |
| Net Income | -40,610 | -47,150 | -28,610 | -30,528 |
| Net Change In Cash | 9,954 | 9,179 | 6,599 | 10,056 |
| Cost of Revenue | -14,068 | |||
| Free Cash Flow | -65,848 | -34,042 | -20,997 | -7,298 |
| Cash | 148,572 | 133,320 | 172,422 | 179,747 |
| Basic Shares | 292,723 | 290,046 | 289,496 | 288,905 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
| Revenue | $38,025 | $485,424 | $11,611 | $233,155 |
| Gross Profit | 7,131 | 418,988 | 11,611 | 206,012 |
| EBITDA | -192,158 | 276,246 | -154 | 169,915 |
| EBIT | -223,052 | 216,511 | -2,001 | 156,031 |
| Net Income | -146,398 | 158,519 | -2,210 | 118,918 |
| Net Change In Cash | 38,025 | 485,424 | 11,611 | 233,155 |
| Cost of Revenue | -76,893 | -91,549 | ||
| Free Cash Flow | -121,384 | 204,700 | 186,132 | 8,017 |
| Cash | 133,320 | 386,535 | 476,142 | 594,116 |
| Basic Shares | 289,166 | 314,827 | 318,294 | 269,497 |
Earnings Calls
| Quarter | EPS |
|---|---|
| 2024-03-31 | -$0.14 |
| 2023-12-31 | -$0.17 |
| 2023-09-30 | -$0.10 |
| 2023-06-30 | -$0.11 |
